bn:02615702n
Noun Named Entity
FR
Brigatinib
EN
Brigatinib, sold under the brand name Alunbrig among others, is a small-molecule targeted cancer therapy being developed by Ariad Pharmaceuticals, Inc. Wikipedia
Relations
Sources
PHYSICALLY INTERACTS WITH
Wikidata